First-line Regimen With QL1706 Plus Chemo ± Bev in PDAC Patients

Abroad (travel likely)RecruitingPHASE2

Conditions

Pancreatic Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Fudan University Shanghai Cancer Center, Shanghai, China

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer

Borderline Resectable Pancreatic Ductal Adenocarcinoma · Resectable Pancreatic Adenocarcinoma · Stage I Pancreatic Cancer AJCC v8

Abroad (travel likely)RecruitingPHASE2

Atlanta, United States

Surufatinib Plus Gemcitabine and Nab-paclitaxel vs. Gemcitabine Plus Nab-paclitaxel in Neoadjuvant Therapy for High - Risk Resectable or Borderline Resectable Pancreatic Cancer

Pancreatic Cancer, Adult

Abroad (travel likely)RecruitingPHASE3

Tianjin, China

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma · Stage II Pancreatic Cancer AJCC v8 · Stage III Pancreatic Cancer AJCC v8

Abroad (travel likely)RecruitingPHASE3

Gilbert, United States · Gilbert, United States

Adebrelimab and Chidamide for Pancreatic Cancer

Pancreatic Cancer, Adult

Abroad (travel likely)RecruitingPHASE2

Nanjing, China